IMMUNOGEN INC·4

Dec 13, 10:58 AM ET

IMMUNOGEN INC 4

4 · IMMUNOGEN INC · Filed Dec 13, 2016

Insider Transaction Report

Form 4
Period: 2016-12-09
Transactions
  • Award

    Deferred Share Unit

    2016-12-09+1,50084,163 total
    Exercise: $0.00From: 2017-03-01Common Stock (1,500 underlying)
  • Award

    Stock option (right to buy)

    2016-12-09$1.84/sh+5,000$9,2005,000 total
    Exercise: $1.84From: 2017-03-01Exp: 2026-12-09Common Stock (5,000 underlying)
Footnotes (4)
  • [F1]The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
  • [F2]The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
  • [F3]The deferred share units vest one-half on March 1,2017 and one-half on June 1,2017, contingent upon the individual remaining a director as of each vesting date.
  • [F4]Exercisable as to 2,500 shares commencing on March 1, 2017 and 2,500 shares commencing on June 1, 2017, contingent upon the individual remaining a director as of each vesting date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -